Marchex (NASDAQ:MCHX) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Marchex (NASDAQ:MCHX – Free Report) in a report published on Tuesday. The firm issued a hold rating on the technology company’s stock. Marchex Stock Up 1.1 % MCHX stock opened at $1.83 on Tuesday. The company has a current ratio of 2.37, a quick ratio of 2.37 and a […]
Genocea Biosciences (NASDAQ:GNCA) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences […]
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report released on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. RVNC has been the topic of a number of other reports. Needham & Company LLC lowered Revance Therapeutics from a moderate buy rating to a […]
Birks Group (NYSE:BGI) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Birks Group (NYSE:BGI – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the stock. Birks Group Stock Performance Shares of BGI opened at $2.11 on Tuesday. Birks Group has a 1 year low of $2.07 and a 1 year high of […]
Nabriva Therapeutics (NASDAQ:NBRV) Receives New Coverage from Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Shares of Nabriva Therapeutics stock opened at $0.00 on Wednesday. The firm has a market capitalization of $6,403.00, […]
Educational Development (NASDAQ:EDUC) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Educational Development (NASDAQ:EDUC – Free Report) in a research note issued to investors on Tuesday. The firm issued a strong-buy rating on the stock. Educational Development Trading Down 0.4 % EDUC stock opened at $2.23 on Tuesday. The company has a market capitalization of $19.12 million, a price-to-earnings ratio […]
Veradigm (NASDAQ:MDRX) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the software maker’s stock. Veradigm Stock Down 1.8 % MDRX stock opened at $9.24 on Monday. Veradigm has a 52 week low of $5.01 and a 52 week […]
Tuniu (NASDAQ:TOUR) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Tuniu (NASDAQ:TOUR – Free Report) in a research report released on Sunday morning. The brokerage issued a buy rating on the technology company’s stock. Tuniu Price Performance Shares of NASDAQ TOUR opened at $1.52 on Friday. The business’s 50-day moving average price is $0.88 and its two-hundred day moving […]
Calumet Specialty Products Partners (NASDAQ:CLMT) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the oil and gas company’s stock. Several other analysts have also recently commented on CLMT. TD Cowen reduced their target price on Calumet Specialty […]
Aeterna Zentaris (NASDAQ:AEZS) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Stock Performance Shares of NASDAQ AEZS opened at $3.90 on Friday. The stock has a market cap of $6.99 million, a P/E […]
last updated on 5 Oct 22:29